Hit 2012 imad
NAPLES III Novel Approaches in Preventing or Limiting Event III TriaL Randomised Comparison of Bivalirudin versus Unfractionated Heparin in Patients at.
Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program.
Effect of Bivalirudin on Aortic Valve Intervention Outcomes (BRAVO) Study A Two-Center Registry Study Comparing Bivalirudin and Unfractionated Heparin.
Harvard Medical School Cost-Effectiveness in Acute Coronary Syndromes The ACUITY Economic Study David J. Cohen, M.D., M.Sc. on behalf of the ACUITY Investigators.
